Baird Financial Group
LCTX icon

Baird Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Baird Financial Group’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,439
Closed -$21K – 1530
2019
Q3 		$21K Sell
21,439
-6,350
-23% -$6.58K ﹤0.01% 1499
2019
Q2 		$31K Hold
27,789
– – ﹤0.01% 1516
2019
Q1 		$36K Buy
27,789
+6,168
+29% +$7.67K ﹤0.01% 1280
2018
Q4 		$20K Sell
21,621
-3,092
-13% -$4.74K ﹤0.01% 1261
2018
Q3 		$49K Buy
24,713
+117
+0.5% +$246 ﹤0.01% 1319
2018
Q2 		$44K Hold
24,596
– – ﹤0.01% 1271
2018
Q1 		$58K Hold
24,596
– – ﹤0.01% 1240
2017
Q4 		$46K Hold
24,596
– – ﹤0.01% 1254
2017
Q3 		$61K Sell
24,596
-117
-0.5% -$290 ﹤0.01% 1222
2017
Q2 		$68K Hold
24,713
– – ﹤0.01% 1212
2017
Q1 		$75K Buy
24,713
+4,115
+20% +$11.7K ﹤0.01% 1204
2016
Q4 		$65K Hold
20,598
– – ﹤0.01% 1183
2016
Q3 		$70K Hold
20,598
– – ﹤0.01% 1182
2016
Q2 		$52K Hold
20,598
– – ﹤0.01% 1184
2016
Q1 		$52K Sell
20,598
-1,730
-8% -$3.86K ﹤0.01% 1203
2015
Q4 		$74K Buy
22,328
+6,840
+44% +$20.4K ﹤0.01% 1216
2015
Q3 		$38K Buy
15,488
+2,478
+19% +$6.42K ﹤0.01% 1234
2015
Q2 		$38K Buy
+13,010
New +$50.4K ﹤0.01% 1297

Other funds holding LCTX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Baird Financial Group's LCTX Position: Q4 2019 in Review

Baird Financial Group sold out of Lineage Cell Therapeutics (LCTX) in Q4 2019, closing a stake of 21,439 shares — an estimated $21K sold.

Baird Financial Group first reported a position in LCTX in Q2 2015 and held it in 18 quarters. The position peaked at $75K in Q1 2017. 108 funds tracked by Wall St. Rank hold LCTX as of Q4 2019.

  • Baird Financial Group reported no remaining Lineage Cell Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Baird Financial Group sold 21,439 Lineage Cell Therapeutics shares in Q4 2019, an estimated $21K.
  • Baird Financial Group first reported a position in Lineage Cell Therapeutics in Q2 2015 and held it in 18 quarters.
  • Baird Financial Group's Lineage Cell Therapeutics position peaked at $75K in Q1 2017.
  • 108 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q4 2019.

Based on Baird Financial Group's 13F filing for Q4 2019, filed 14 Feb 2020.